NIH PAR · NHGRI · R01
PAR-25-371: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this NOFO is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. Direct involvement of key stakeholders where appropriate is encouraged. This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Applications without a PEDP will not be reviewed.
- NOFO number
- PAR-25-371
- Type
- PAR
- Activity code
- R01
- Primary institute
- NHGRI · National Human Genome Research Institute
- Clinical trials
- Optional
- Posted
- Jan 13, 2025
- Opens
- Jan 20, 2025
- Expires
- Nov 19, 2026
PAR-25-371 due dates
1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 20, 2025 | March 19, 2025 | Not Applicable | July 2025 | October 2025 | December 2025 |
| June 17, 2025 | July 18, 2025 | Not Applicable | November 2025 | January 2026 | April 2026 |
| October 20, 2025 | November 18, 2025 | Not Applicable | March 2026 | May 2026 | July 2026 |
| February 19, 2026 | March 18, 2026 | Not Applicable | July 2026 | October 2026 | December 2026 |
| June 18, 2026 | July 20, 2026 | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 20, 2026 | November 18, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
Projects funded under PAR-25-371
NIH RePORTER lists 8 projects funded under PAR-25-371 in FY2022–FY2026, with $7.8M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
8
Distinct projects, FY2022–FY2026
New awards
8
Type 1 (new project) award records
NIH funding
$7.8M
Award dollars under PAR-25-371, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 8 | 8 | $7.8M |
Institutions with the most funding
- New York University School of Medicine$2.7M · 1 project
- University of Connecticut Sch of Med/Dnt$849K · 1 project
- University of California, San Francisco$842K · 1 project
- Boston Children's Hospital$823K · 1 project
- Massachusetts General Hospital$769K · 1 project
- Harvard Pilgrim Health Care, Inc.$763K · 1 project
- Stanford University$546K · 1 project
- Children's Mercy Hosp (Kansas City, Mo)$465K · 1 project
Funding institutes
- NHGRI$4.1M · 3
- NICHD$2.9M · 4
- NIDA$769K · 1
Activity codes funded
- R018 records
Most recent new awards
- Critical ELSI Issues to Address in Implementing Genomic Newborn Screening (opens NIH RePORTER)
Boston Children's Hospital · 1R01HD120961-01A1 · NICHD · Notice Sep 17, 2026
$823KR01
- Genetic Medicine and Pregnancy Management in Varied Health Policy Environments (opens NIH RePORTER)
University of California, San Francisco · 1R01HD124734-01 · NICHD · Notice Sep 17, 2026
$842KR01
- ELSI of epigenetic NIPT: Patient, provider, and community input on clinical implementation (opens NIH RePORTER)
Children's Mercy Hosp (Kansas City, Mo) · 1R01HD119556-01A1 · NICHD · Notice Sep 16, 2026
$465KR01
- Developing a framework for the clinical translation of multi-omic technologies in rare diseases (opens NIH RePORTER)
Stanford University · 1R01HG014572-01A1 · NHGRI · Notice Sep 4, 2026
$546KR01
- Leveraging a Card Study Methodology to Promote Integration of Genetics in Primary Care (opens NIH RePORTER)
University of Connecticut Sch of Med/Dnt · 1R01HG015102-01 · NHGRI · Notice Sep 4, 2026
$849KR01
- Ethical Considerations and Barriers to Generalizable Evidence and Data Sharing for Individualized Genomic Therapies (opens NIH RePORTER)
New York University School of Medicine · 1R01HG014543-01A1 · NHGRI · Notice Aug 25, 2026
$2.7MR01
What its predecessor PAR-23-293 funded
PAR-25-371 reissues PAR-23-293. Its funding history is the best guide to who wins under this program: 6 projects and $12.6M in FY2022–FY2026.
Projects funded
6
Distinct projects, FY2022–FY2026
New awards
5
Type 1 (new project) award records
NIH funding
$12.6M
Award dollars under PAR-23-293, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 5 | 4 | $8.7M |
| FY2026 | 4 | 1 | $3.9M |
Institutions with the most funding
- Feinstein Institute for Medical Research$3.3M · 1 project
- Seattle Children's Hospital$3.3M · 1 project
- University of Washington$2.3M · 1 project
- Columbia University Health Sciences$1.7M · 1 project
- UT Southwestern Medical Center$1.1M · 1 project
- Stanford University$927K · 1 project
Funding institutes
- NHGRI$11.5M · 7
- NCI$1.1M · 2
Activity codes funded
- R019 records
Most recent new awards
- Democratizing Genomic Data Science: Exploring the Impact of Cloud-Based Platforms on Data Access and Use (opens NIH RePORTER)
University of Washington · 1R01HG014544-01 · NHGRI · Notice May 4, 2026
$2.3MR01
- SERVICE: Newborn genomic sequencing and federally-supported early intervention (opens NIH RePORTER)
Seattle Children's Hospital · 1R01HG014062-01A1 · NHGRI · Notice Sep 25, 2025
$3.3MR01
- Disability, Disparities and Data Solidarity in Translational Genomic Research: The 3D-People Project (opens NIH RePORTER)
Columbia University Health Sciences · 1R01HG014564-01 · NHGRI · Notice Sep 24, 2025
$878KR01
- The Ethics of Engagement in Patient-Focused Drug Development for Rare Diseases (opens NIH RePORTER)
Stanford University · 1R01HG014059-01 · NHGRI · Notice Jan 31, 2025
$671KR01
- Developing Consensus on a Practical Framework for Variant Reclassification and Recontact (opens NIH RePORTER)
UT Southwestern Medical Center · 1R01CA304065-01 · NCI · Notice Dec 25, 2024
$542KR01
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
14 NIH institutes and offices take applications under PAR-25-371. Contact the program officer at the institute that fits your research before applying.
- NHGRI · National Human Genome Research Institute
- NEI · National Eye Institute
- NIAID · National Institute of Allergy and Infectious Diseases
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDCD · National Institute on Deafness and Other Communication Disorders
- NIDA · National Institute on Drug Abuse
- NIEHS · National Institute of Environmental Health Sciences
- NIMH · National Institute of Mental Health
- NINDS · National Institute of Neurological Disorders and Stroke
- NIMHD · National Institute on Minority Health and Health Disparities
- NCI · National Cancer Institute
- THRO
- OBSSR
- ORWH
Related notices
Nov 13, 2023 · NOT-HG-24-010
Notice of Pre-Application Webinar for Ethical, Legal and Social Implications ELSI) Research: PAR-23-293 R01 Clinical Trial Optional), PAR-23-294 R21 Clinical Trial Optional) and PAR-23-295 R03 Clinical Trial Optional).
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewRenewalResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are not limited but need to reflect the actual needs of the proposed project.Budgets should include costs required to implement the proposed Data Management and Sharing Plan and the proposed Resource Sharing Plan
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is 5 years, but given how quickly the field changes, it is expected that some projects will be no more than 4 years in duration. Longer project periods should be well justified. Additional consideration for longer projects may be given to new or early stage investigators or projects proposing…
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-23-293.
- Companion NOFOs: PAR-25-369, PAR-25-370.
Other open NOFOs for R01
- RFA-HG-25-009Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)NHGRI · next due Feb 26, 2027
- PAR-25-255Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)NHGRI
- PAR-25-322Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)OD · next due Jan 26, 2027
- PA-25-301NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)NIH · next due Feb 5, 2027
- PA-25-305NIH Research Project Grant (Parent R01 Clinical Trial Required)NIH · next due Feb 5, 2027
- PAR-25-144Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.